Colorectal Cancer Clinical Trials
Amgen (CodeBreak 301)
Phase 3 Multicenter, Randomized, Open label, Active controlled Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab awwb for Treatment naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301).
M24-064
Phase 3 Colorectal Cancer.
ABBVIE M24-533
M24-533: A Phase 2, Open-Label, Randomized, Master Protocol Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations with ABBV-400 in Subjects with Metastatic Colorectal Cancer.
TAK-113-4002
A trial to evaluate the safety and activity of fruquintinib in minority populations with advanced, previously treated colorectal cancer. A Single Arm Phase 4 Trial to Evaluate the Safety and Efficacy of Oral Fruquintinib in the Treatment of Refractory Metastatic. Colorectal Cancer in Patients from Minority Populations Underrepresented in Prior Fruquintinib Studies.